Skip to search formSkip to main contentSkip to account menu

bispecific antibody 2B1

Known as: MoAb 2B1 Bispecific, 2B1 Bispecific Murine MAb, BsAb 2B1 
A monoclonal antibody with potential antineoplastic activity. Specific for both the immunoglobulin G (IgG) receptor CD16 and c-erbB-2, bispecific… 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2007
2007
Purpose: Overexpressed cytokine receptors are considered valid targets for new biologicals targeting prostate cancer. However… 
2007
2007
We report two preliminary trials of antibody treatment of B-cell lymphoma. Advanced lymphoma was treated with chimeric FabFc2, in… 
2000
2000
Abstract. In the lung the expression of xenobiotic-metabolizing enzymes such as cytochromes P450 (CYP) and glutathione S… 
1998
1998
For the treatment of minimal residual disease in patients with leukemias and malignant lymphomas, we constructed a heterodimeric… 
1998
1998
Cytochrome P450 2B1 clones were isolated from a phenobarbital-induced Wistar-Kyoto (WKY) hepatic cDNA library and were found to… 
1996
1996
To develop an effective immunotherapy for B-lineage acute lymphoblastic leukemia (ALL), bispecific monoclonal antibodies (bsAb… 
1995
1995
The heterodimer-forming leucine zippers Fos and Jun can efficiently mediate the formation of bispecific F(ab')2 when they are… 
1995
1995
A bispecific antibody directed to T and B cells (CD3×CD19 bsAb) was daily infused intravenously in escalating doses from 10 μg up… 
1993
1993
A panel of bispecific F(ab')2 antibodies (BsAb) have been constructed for delivering the ribosome-inactivating protein saporin to…